Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 17, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Oncogenic mutations in K-Ras CaM interactions

MegaLMM: A software program for genomic predictions

ATF4: A stress-responsive factor in mTORC1 signaling

Oncogenic mutations in K-Ras CaM interactions
  • BiotechToday
  • World

Oncogenic mutations in K-Ras CaM interactions

BioTech Today July 27, 2021July 26, 2021

Husna, Amity University Kolkata

What is K-Ras-CaM interaction?

K-Ras is an oncogenic mutant that helps the cancer cells to proliferate, migrate, invade, and survive by assembling some signalling complexes. These complexes have a great therapeutic and mechanistic significance, however, to date, the functional and structural roles of K-Ras mutations within these complexes are not completely understood. K-Ras GTPase specifically binds to a calcium sensor known as calmodulin (CaM). This binding helps to regulate signal transduction in cancer and it remains the primary focus of intense research. 

Recent study: A 2021 study has reviewed recent advances to understand specific binding between K-Ras and calmodulin (calcium sensor). The review published in Current Opinion in Structural Biology has highlighted the key features of the interaction between wild-type K-Ras and calmodulin (CaM).

Insights into K-Ras-CaM interaction:

For the development of a proper signalling cascade, tight spatial and temporal regulation of proteins is highly essential. A ubiquitous regulator of many essential cellular signalling processes in health and disease is calmodulin (CaM). Calmodulin (CaM) is a small protein that is 148 amino acids long and it comprises two globular domains that are connected by a flexible linker. Each of the domains can bind two calcium ions. However, the calcium affinity of the N-terminal domain is lower in comparison to the C-terminal domain; this difference in affinity allows CaM’s conformations to adapt in response to changing calcium concentrations. Protein-protein complexes involving CaM are highly sensitive to environmental conditions and it depends on pH and concentrations of metal ions. 

So, the binding of CaM to other proteins can modulate signalling cascades. GTPases are one of these groups of proteins, they are a family of signal transduction proteins. CaM is able to bind to several members of this family, followed by controlling their signalling cascades in a disease-specific manner. Ras family of GTPases, particularly Kirsten Ras isoform B (K-Ras4B), are vital oncogenic proteins that drive the cancer of epithelial origin, such as pancreatic, lung, and colorectal malignancies. 

K-Ras lacks the ability to be palmitoylated; it is polybasic and its hypervariable region on C-terminal is carboxymethylated and farnesylated. So, these are the distinct features of K-Ras’s HVR, responsible for selective binding to CaM As the functions of K-Ras in cancer cells can directly be regulated by CaM so this interaction is a focus of intense research. 

Oncogenic mutations of K-Ras alter the nature of interaction with CaM:

Oncogenic mutations in K-Ras occur at position 12 which inhibits the hydrolysis of GTP and traps the enzyme in a constitutively active state. Due to oncogenic mutations, there is a differential preference of membrane components and distinct signalling pathways which can further modulate CaM’s ability to extract oncogenic K-Ras from the membrane. By using isothermal titration calorimetry, it was shown that farnesylation is unlikely to be the only essential requirement in the formation of the K-Ras/CaM complex and instead it might strengthen this interaction further and help to attain a physiologically relevant affinity of oncogenic K-Ras for CaM.

Significance of the study:

• Studies of calmodulin complexes (CaM) with oncogenic mutants of K-Ras can give insights into the invention of some novel regulatory mechanisms, especially in cancer.

• Insights into K-Ras/CaM interactions may help to design some selective drugs.

Also read: Reverse optogenetics tool using zebrafish

Reference:

  1. Abdelkarim, H., Leschinsky, N., Jang, H., Banerjee, A., Nussinov, R., & Gaponenko, V. (2021). The dynamic nature of the K-Ras/calmodulin complex can be altered by oncogenic mutations. Current Opinion in Structural Biology, 71, 164–170. https://doi.org/10.1016/j.sbi.2021.06.008
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Author info:

Husna is an undergraduate student of BTech Biotechnology at Amity University Kolkata. She is a research enthusiast in Immunology and Immunotherapy but she has a keen interest in various other Bioscience subjects as well. She is constantly focused on improving her knowledge and laboratory skills through various internships. She is a Scientific content writer who has knowledge in diverse backgrounds of Biotechnology.

Publications:

  • https://bioxone.in/news/worldnews/is-the-frequent-prescription-of-ppi-medicines-a-boon-or-a-bane/
  • https://bioxone.in/news/worldnews/role-of-lysosomes-and-%CE%B1-synuclein-fibrils-in-protein-misfolding/

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged calcium affinity Calmodulin complexes CaM cancer cANCER bIOLOGY farnesylation K-Ras-CaM interactions Oncogenes oncogenic mutants oncogenic mutations signalling cascades Signalling Pathways

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

ATF4: A stress-responsive factor in mTORC1 signaling

BioTech Today July 27, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University For a very long time, researchers have been searching for ways to increase human life. In this quest, they have found one promising protein -mTOR. The finding of mTOR has given rise to a whole field in cellular biology that studies mTOR and its associated pathway.  mTOR- […]

ATF4

Related Post

  • BiotechToday
  • World

Green synthesis of graphite with Carbon dioxide

bioxone January 13, 2021January 13, 2021

PRIYANKA CHAKRABORTY, AMITY UNIVERSITY, KOLKATA Carbon has always been applied in the fields such as metallurgy, environmental remediation, conversion, automotive industry, etc as it has extensive physicochemical properties. In this report, an efficient approach to making graphite from carbon dioxide at low temperatures in the absence of metal catalysts has been suggested. CO2 is converted […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • World

A GREAT MANUFACTURING INNOVATION BY OXGENE

bioxone September 24, 2020September 24, 2020

Subhangi Das, Bankura Sammilani College OXGENE has developed scalable gene therapy technology, marking the day as the launch of its scalable, plasmid-free technical system for AAV. OXGENE ‘s new TESSA technology is a great illustration of the change in AAV manufacturing.  Adeno associated virus or AAV having benefits such as low immunogenicity and a favorable […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

MYCN protein expression level in neuroblastoma patients predicts prognosis better

BioTech Today February 3, 2023February 3, 2023

Charvy Rana, Department of Pathology, AIIMS, New Delhi What is MYCN protein? Cancer often involves the inactivation of tumor-suppressor genes and/or over-activation of oncogenes. The MYCN proto-oncogene is one such example, implicated for its amplified or “oncogenic” status in several neuronal and non-neuronal cancers (those of lung, ovaries, prostate, and more)1. Normally expressed during the […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy